Yahoo India Web Search

Search results

  1. David O'Malley. Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised ….

  2. David M O'Malley, MD, is a Gynecologic Oncology Specialist, specializing in Cervical Cancer at the OSUCCC – James. Learn more.

  3. David O’Malley, MD, gynecologic oncologist at The Ohio State Wexner Medical Center and The OSUCCC—James, shares why he entered this important field in women’...

    • 2 min
    • 1242
    • Ohio State Wexner Medical Center
  4. View David OMalley’s profile on LinkedIn, a professional community of 1 billion members. Experience: Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research ...

    • 500+
    • Columbus, Ohio, United States
  5. www.oncologynewscentral.com › david-omalleyDavid O’Malley, MD

    David O’Malley, MD, is a Professor in the Department of Obstetrics and Gynecology at The Ohio State University College of Medicine and Director of the Division of Gynecologic Oncology at Ohio State University Comprehensive Cancer Center (OSUCCC) - James, where he leads that division with GOG Partners. Dr.

  6. David M. O’Malley, MD, discusses cervical cancer epidemiology, risk factors, and diagnosis, highlighting the importance of HPV vaccinations, regular PAP smears, and the use of various biomarkers ...

  7. People also ask

  8. David O’Malley, MD, professor, Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, and director, Division of Gynecologic ...

    • 1 min
    • 123
    • OncLiveTV